Skip to content
Tenfell
Awarded contract
Published 11 Jun 2024

NHS Framework - Blood Disorders including Haemophilia A and B - July 2024

NHS England · London

Key facts

Awarded
30 May 2024
Procedure
Open procedure (framework)
Buyer type
Central government

Awarded to 9 suppliers

SupplierValue
Pfizer Ltd—
Takeda UK Limited—
Octapharma Limited—
Novo Nordisk—
Sobi (Swedish Orphan Biovitrum Ltd)—
Roche Products Ltd—
CSL Behring UK Ltd—
LFB—
Bio Products Laboratory—

Description

Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024

Offer reference number: CM/PHS/22/5661

Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 14 months.

Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.